Request 1

Do you currently have any enhanced (non GMS or PMS) service contracts involving prostate cancer and/or Leuteinising Hormone-Releasing Hormone Analogue (LHRHa) administration with GP practices?

Response 1

Yes

Request 2

Does this service involve payments for the administration of the following LHRHA’s please indicate which?

1.  Zoladex (Goserelin)
2. Prostap (Leuprorelin)

                                  iii.     Decapeptyl (Triptorelin)

Response 2

No

Request 3

What is the frequency of payment? 

Response 3

Not applicable

Request 4

What is the payment amount? 

Response 4

Not applicable

Request 5

Does the service include other factors such as:

• PSA
• symptom questionnaires
• patient review follow ups 

Response 5

The enhanced service is for PSA testing

Request 6

Is there a specific payment for this? 

Response 6

Yes - £32 per patient per year as of 1^st October 2017